Given the high demand of tumor cells for glutamine, it can be reasonably inferred that certain selective amino acids must be upregulated in tumor cells to meet this requirement
S6E,F) and not in hAEC (Supplementary Fig
Oral or troche dose: Determined at APRN intake based on your GI indication and treatment goal Troche format: Held sublingually for 60 to 90 seconds before swallowing for improved absorption Best use case: GI inflammation, IBS, gut lining repair, Crohns management, systemic anti-inflammatory support Not optimal for: Localized tendon, joint, or muscle injury where injection near the site is more targeted Injury vs Gut Protocol: See What Dosing Looks Like for Your Use Case BPC-157 dosage differs by indication
This maximises stability during storage and transport
Oncogenic Potential (Cancer Risk) Both peptides encourage angiogenesis (blood vessel growth) and cell proliferation
The well-recognized early complications are the incomplete release of TCL, neuropraxia or injury to the median or ulnar nerve, inadvertent entry to Guyon's canal (the tunnel between the pisiform and hamate bone and the ligament connecting both bones), injury to the palmar cutaneous or recurrent motor branch of the median nerve and injury to the superficial palmar arch or ulnar artery
